EDITAS MEDICINE, INC. Repayments of Long-Term Debt
EDITAS MEDICINE, INC. (EDIT) reported Repayments of Long-Term Debt of $2.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2018-03-08
- EDITAS MEDICINE, INC. repayments of long-term debt for the quarter ending 2015-12-31 was $1.93M.
- EDITAS MEDICINE, INC. repayments of long-term debt for the quarter ending 2015-09-30 was $42.00K.
- EDITAS MEDICINE, INC. repayments of long-term debt for fiscal 2015 was $2.00M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2015-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $1.97M derived: sum of 2 quarters · filed 2018-03-08 | $2.00M 10-K · filed 2018-03-08 | |
| 2015-09-30 | $42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $70.00K 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | $28.00K 10-Q · filed 2016-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |